|
Name |
1-Bromodocosane
|
Molecular Formula | C22H45Br | |
IUPAC Name* |
1-bromodocosane
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCCCCBr
|
|
InChI |
InChI=1S/C22H45Br/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23/h2-22H2,1H3
|
|
InChIKey |
QYOXLKAKUAASNA-UHFFFAOYSA-N
|
|
Synonyms |
1-Bromodocosane; 6938-66-5; Docosane, 1-bromo-; Behenyl bromide; Docosyl bromide; n-Docosyl bromide; docosylbromide; EINECS 230-069-4; 2-Chloro-3-pyridineaceticacid; SCHEMBL318151; DTXSID3064510; NSC53991; ZINC6921162; MFCD00013543; NSC 53991; NSC-53991; AKOS015843178; DB-055266; B0392; CS-0152202; FT-0607526; A22880; F11114; EN300-6494012; 5-(p-nitrophenyl)-2-furaldehyde;5-(P-Nitrophenyl)-2-furancarbaldehyde
|
|
CAS | 6938-66-5 | |
PubChem CID | 81355 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 389.5 | ALogp: | 12.5 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 20 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 23 | QED Weighted: | 0.125 |
Caco-2 Permeability: | -5.162 | MDCK Permeability: | 0.00000549 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.284 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.015 | Plasma Protein Binding (PPB): | 98.52% |
Volume Distribution (VD): | 4.516 | Fu: | 1.21% |
CYP1A2-inhibitor: | 0.076 | CYP1A2-substrate: | 0.155 |
CYP2C19-inhibitor: | 0.19 | CYP2C19-substrate: | 0.055 |
CYP2C9-inhibitor: | 0.046 | CYP2C9-substrate: | 0.958 |
CYP2D6-inhibitor: | 0.154 | CYP2D6-substrate: | 0.045 |
CYP3A4-inhibitor: | 0.167 | CYP3A4-substrate: | 0.024 |
Clearance (CL): | 3.451 | Half-life (T1/2): | 0.022 |
hERG Blockers: | 0.41 | Human Hepatotoxicity (H-HT): | 0.026 |
Drug-inuced Liver Injury (DILI): | 0.699 | AMES Toxicity: | 0.056 |
Rat Oral Acute Toxicity: | 0.064 | Maximum Recommended Daily Dose: | 0.048 |
Skin Sensitization: | 0.968 | Carcinogencity: | 0.05 |
Eye Corrosion: | 0.993 | Eye Irritation: | 0.941 |
Respiratory Toxicity: | 0.691 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000442 | 0.861 | D00AOJ | 0.861 | ||||
ENC000449 | 0.861 | D07ILQ | 0.512 | ||||
ENC000923 | 0.827 | D00STJ | 0.496 | ||||
ENC000446 | 0.827 | D00FGR | 0.479 | ||||
ENC000755 | 0.827 | D0Z5SM | 0.458 | ||||
ENC000761 | 0.819 | D05ATI | 0.390 | ||||
ENC000432 | 0.819 | D0O1PH | 0.385 | ||||
ENC001173 | 0.805 | D0T9TJ | 0.320 | ||||
ENC000359 | 0.795 | D0P1RL | 0.302 | ||||
ENC000433 | 0.795 | D0Z1QC | 0.295 |